Dr. Robin R. Blum is a board certified fellow of the American Academy of Dermatology. She graduated cum laude from Tufts University in Medford, MA, and earned her degree in medicine from Tufts University School of Medicine in Boston, MA.
Dr. Blum graduated medical school with Honors in recognition of her devotion to scientific research.
Dr. Blum completed her internal medicine internship and dermatology...Read More
Dr. Robin R. Blum is a board certified fellow of the American Academy of Dermatology. She graduated cum laude from Tufts University in Medford, MA, and earned her degree in medicine from Tufts University School of Medicine in Boston, MA.
Dr. Blum graduated medical school with Honors in recognition of her devotion to scientific research.
Dr. Blum completed her internal medicine internship and dermatology residency at Mount Sinai Medical Center in New York, NY. During her final year at Mount Sinai she served as Chief Resident. Dr. Blum furthered her education and training by completing a two-year fellowship in dermatopharmacology, during which she studied emerging therapies in psoriasis, eczema, and acne.
Dr. Blum has authored numerous articles published in a variety of medical journals, and her medical research has been presented at dermatologic conferences throughout the world.
Dr. Blum has been appointed Assistant Clinical Professor at Mount Sinai Medical Center’s Department of Dermatology, and participates in the training and education of medical students, residents, and fellows.
Dr. Blum specializes in adult and pediatric medical dermatology, as well as cosmetic dermatology. She has extensive experience with botox, injectable fillers, chemical peels, and a variety of lasers.
The Mount Sinai Hospital, Internship in Internal Medicine
The Mount Sinai Hospital, Residency in Dermatology
Medical School - Tufts University
The Mount Sinai Hospital, Internship in Internal Medicine
The Mount Sinai Hospital, Residency in Dermatology
Board Certifications
American Board of Dermatology
American Board of Dermatology
Awards and Publications
Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol 2006; 55:...Read More
Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol 2006; 55: 637-641.
Papp, KA, et al. Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial. Int J Dermatol 2006; 45: 605-614.
Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M. An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis. J Am Acad Dermatol 2005; 53: 73-75.
Paller AS, Lebwohl M, Fleischer AB, Antanya R, Langley RG, Kirsner RS, Blum RR, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 2005; 52: 810-822.
Lebwohl M, Blum R, Berkowitz E, Kim Dennis, Zitnik R, Osteen C, Wallis WJ. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years. Arch Dermatol 2005; 141: 861-864.
Blum RR, Wong VK, Lebwohl M. Alefacept-revolutionizing psoriasis therapy. Today’s Ther Trends 2003; 21:97-116.
Blum RR, Lebwohl MG. Combination therapy with retinoids plus UVB. A CME case study publication, 2003.
Blum RR. Dermatology. First Aid for the Medicine Clerkship. (Stead L, Kaufman M, Stead SM, eds), McGraw-Hill, New York, pp 307-334, 2002.
Marghoob AA, Blum RR, Nossa R,, Busam K, Sachs D, Halpern A. Agminated atypical (dysplastic) nevi: case report and review of the literature. Arch Dermatol 2001; 137: 917-920.
Blum RR, Rahimizadeh A, Kardon N, Lebwohl M, Wei H. Genital lentigines in a 6-year-old boy with a family history of Cowden’s disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden’s disease. J Cutan Med Surg 2001; 5: 228-230.
Blum RR, Phelps RG, Wei H. Arthropod bites manifesting as recurrent bullae in a patient with chronic lymphocytic leukemia. J Cutan Med Surg 2001; 5: 312-314.
Blum RR, Lu Y, Shoji T, Lebwohl M, Wei H. DNA damage and proliferating cell nuclear antigen in hairless mice simultaneously exposed to Benzopyrene and UVA radiation. J Invest Dermatol 2000; 114:764., Wei H, Lu Y, Blum RR, Lebwohl M. Modulation of UV radiation-activated signal transduction cascades by an herbal flavanoid baicalein. J Invest Dermatol 2000; 114:805.
Cohen BM, Weber VJ, Blum RR, Ruck BE, Cohen DE, Haik BJ, Colette RH. Cocktail attenuation of rotational ablation flow effects (CARAFE) study. Cathet Cardiovasc Diagn 1996; 3:69-72.
Curwin JH, Blum RR, Winters SL. Age related differences in the response to head up tilt. J Am Coll Cardiol 1996; 27:18A.
Curwin JH, Goldman DS, Blum RR, Banas JS, Winters SL. Electrode catheter ablation of tachycardias in the elderly: relative indications, results, and complications. Am J Geriatr Cardiol 1996; 5:49.
